CoChat

The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside

Agache, Ioana, Sugita, Kazunari, Morita, Hideaki, Akdis, Mübeccel, Akdis, Cezmi A. · 2015 · Current Allergy and Asthma Reports

The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.

Abstract

Better management of allergic diseases needs a sharpened understanding of disease heterogeneity and mechanisms in relation to clinically significant outcomes. Phenotypes describing observable clinical and morphologic characteristics and unique responses to treatment have been developed; however, they do not relate to disease mechanisms. Recently, extended heterogeneous and disease-related metabolic, inflammatory, immunological, and remodeling pathways have been described, and reproducible patterns are defined as disease endotypes. An endotype might consist of several intricated mechanisms that cannot be clearly separated into "pure single molecular mechanism" thus being a "complex endotype." The description of an endotype may rely on biomarkers, which can be the signature of a complex underlying pathway or a key molecule associated with or directly playing a role in a particular disease endotype. The Th2 type inflammation can be defined as a complex endotype in asthma and linked to mechanisms of disease development and response to treatment and to disease outcomes such as exacerbations and remodeling. The type 2 complex endotype in allergies and asthma includes innate lymphoid cells, T helper 2 cells, tissue eosinophilia, and IgE production. Currently, emerging endotype-driven strategies in asthma, particularly the development of biologicals that target a single molecular pathway, are being focused for solving individualized clinical problems on disease outcomes. Progress is also being made for endotyping rhinitis, chronic rhinosinusitis, and atopic dermatitis.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11882-015-0529-x

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 76 references

Research works printed but not linked: 1

  1. Akdis M, Akdis C. Immune tolerance. In: Bochner BS, Adkinson Jr NF, Burks W, Busse WW, Holgate Jr ST, Lemanski RF, O’Hehir RE, editors. Middleton’s allergy. 8th ed. Cambridge: Elsevier; 2013.

Cited by

See all 90

Metadata

Authors
Agache, I., Sugita, K., Morita, H., Akdis, M., & Akdis, C. A.
Affiliations
  • Transilvania University of Brașov (RO)
  • University of Zurich (CH)
Corresponding author
Agache, Ioana
Venue
Current Allergy and Asthma Reports
Published
2015-06
Volume
15
Issue
6
Pages
29-29
ISSN
  • 1529-7322 (ISSN-L)
  • 1534-6315
OpenAlex
W1192231709
Cited by
86
References
77
Citations by year
2026: 4 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 13 · 2019: 8 · 2018: 13 · 2017: 10 · 2016: 14 · 2015: 5
FWCI
1.71
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Allergy and Asthma Reports (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
allergic diseases, asthma, allergy, type 2 inflammation, innate lymphoid cells, Th2 cells, tissue eosinophilia, IgE, airway remodeling, asthma exacerbations, biologic therapy, endotyping, rhinitis, chronic rhinosinusitis, atopic dermatitis, disease heterogeneity
MeSH terms
Asthma, Eosinophils, Humans, Hypersensitivity, Phenotype, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside. https://app.cochat.ai/papers/10.1007/s11882-015-0529-x
The paper
Agache, I., Sugita, K., Morita, H., Akdis, M., & Akdis, C. A. (2015). The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside. Current Allergy and Asthma Reports. https://doi.org/10.1007/s11882-015-0529-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.